Fu Zhang

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A small-molecule self-assembled nano-prodrug for enhanced therapy of cancer stem cell-enriched pancreatic ductal adenocarcinoma.

A small-molecule self-assembled nano-prodrug for enhanced therapy of cancer stem cell-enriched pancreatic ductal adenocarcinoma.

Journal: Acta biomaterialia

Published: March 24, 2026

Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer.

Antigen Spreading via Localized Administration Enhances Adoptive TCR-T Cell Therapy in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 15, 2026

Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Correction: Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.

Journal: Journal of nanobiotechnology

Published: January 03, 2025

Engineered a Gemcitabine Nano-Prodrug Targeting Desmoplastic Pancreatic Tumor with Dual Enhancement of Penetration Dynamics.

Engineered a Gemcitabine Nano-Prodrug Targeting Desmoplastic Pancreatic Tumor with Dual Enhancement of Penetration Dynamics.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: November 08, 2024

Combination of anti-inflammatory therapy and RNA interference by light-inducible hybrid nanomedicine for osteoarthritis treatment.

Combination of anti-inflammatory therapy and RNA interference by light-inducible hybrid nanomedicine for osteoarthritis treatment.

Journal: Acta pharmaceutica Sinica. B

Published: April 03, 2024

A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.

A homologous membrane-camouflaged self-assembled nanodrug for synergistic antitumor therapy.

Journal: Acta biomaterialia

Published: January 22, 2024

Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug.

Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug.

Journal: Asian journal of pharmaceutical sciences

Published: April 11, 2023

A Self-Assembly Nano-Prodrug for Combination Therapy in Triple-Negative Breast Cancer Stem Cells.

A Self-Assembly Nano-Prodrug for Combination Therapy in Triple-Negative Breast Cancer Stem Cells.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: February 22, 2023

A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator.

A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulator.

Journal: Biomedical materials (Bristol, England)

Published: December 21, 2022

In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.

In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.

Journal: Advanced healthcare materials

Published: December 15, 2022

An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer.

An Ionic Liquid Ablation Agent for Local Ablation and Immune Activation in Pancreatic Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 21, 2022

A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.

A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.

Journal: Acta biomaterialia

Published: September 20, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026